Trevi Therapeutics
Biotechnology, 195 Church St, New Haven, Connecticut, 06510, United States, 11-50 Employees
Phone Number: 12*********
Who is TREVI THERAPEUTICS
Trevi Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational oral therapy HaduvioTM (nalbuphine ER). Hadu...
Read More
-
Headquarters: 195 Church St, New Haven, Connecticut, 06510, United States
-
Date Founded: 2011
-
Employees: 11-50
-
Revenue: $25 Million to $50 Million
-
Active Tech Stack: See technologies
Industry: Biotechnology
SIC Code: 2834
|
NAICS Code: 561110 |
Show More
Does something look wrong? Fix it. | View contact records from TREVI THERAPEUTICS
Trevi Therapeutics Org Chart and Mapping
Email
Phone
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding Trevi Therapeutics
Answer: Trevi Therapeutics's headquarters are located at 195 Church St, New Haven, Connecticut, 06510, United States
Answer: Trevi Therapeutics's phone number is 12*********
Answer: Trevi Therapeutics's official website is https://trevitherapeutics.com
Answer: Trevi Therapeutics's revenue is $25 Million to $50 Million
Answer: Trevi Therapeutics's SIC: 2834
Answer: Trevi Therapeutics's NAICS: 561110
Answer: Trevi Therapeutics has 11-50 employees
Answer: Trevi Therapeutics is in Biotechnology
Answer: Trevi Therapeutics contact info: Phone number: 12********* Website: https://trevitherapeutics.com
Answer: Trevi Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational oral therapy HaduvioTM (nalbuphine ER). Haduvios unique centrally and peripherally active mechanism of action (MOA) has the potential to rebalance the kappa and mu receptors which may play a significant role in chronic cough. Haduvio demonstrated a 75% reduction in daytime cough frequency for idiopathic pulmonary fibrosis (IPF) patients in its Phase 2 Cough And NALbuphine trial. With this positive data, Trevi is focusing future clinical development on chronic cough conditions, including IPF, interstitial lung diseases, and refractory chronic cough. Trevi is headquartered in New Haven, CT.
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Sign in to CIENCE GO Data to uncover contact details
Free credits every month